DCM
BIO icon

Daruma Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Daruma Capital Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-15,478
Closed -$3.69M – 51
2017
Q4 		$3.69M Hold
15,478
– – 0.23% 44
2017
Q3 		$3.44M Sell
15,478
-82
-0.5% -$18.5K 0.21% 46
2017
Q2 		$3.52M Sell
15,560
-4,788
-24% -$1.04M 0.21% 45
2017
Q1 		$4.06M Hold
20,348
– – 0.24% 39
2016
Q4 		$3.71M Buy
20,348
+1,131
+6% +$193K 0.21% 37
2016
Q3 		$3.15M Sell
19,217
-1,175
-6% -$178K 0.19% 37
2016
Q2 		$2.92M Buy
+20,392
New +$2.91M 0.19% 47

Other funds holding BIO

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return